Is LEMAITRE VASCULAR INC (LMAT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 7.6% / 30% | 14.7% / 30% | 1.4% / 30% | 4.99% / 5% | ✓ HALAL |
| DJIM | 7.6% / 33% | 14.7% / 33% | 1.4% / 33% | 4.99% / 5% | ✓ HALAL |
| MSCI | 30.1% / 33% | 58.3% / 33% | 5.5% / 33% | 4.99% / 5% | ✗ NOT HALAL |
| S&P | 7.6% / 33% | 14.7% / 33% | 1.4% / 33% | 4.99% / 5% | ✓ HALAL |
| FTSE | 30.1% / 33% | 58.3% / 33% | 5.5% / 50% | 4.99% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 70.4% | |
| Operating Margin | 21.8% | |
| Net Margin | 23.1% | |
| Return on Equity (ROE) | 15.8% | |
| Return on Assets (ROA) | 6.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $81M |
| Free Cash Flow | $74M |
| Total Debt | $186M |
| Debt-to-Equity | 47.2 |
| Current Ratio | 12.9 |
| Total Assets | $616M |
Price & Trading
| Last Close | $110.33 |
| 50-Day MA | $96.92 |
| 200-Day MA | $89.48 |
| Avg Volume | 200K |
| Beta | 0.7 |
|
52-Week Range
$71.42
| |
About LEMAITRE VASCULAR INC (LMAT)
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Purification Calculator
As a halal stock with 4.99% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is LEMAITRE VASCULAR INC (LMAT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), LEMAITRE VASCULAR INC is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is LEMAITRE VASCULAR INC's debt ratio?
LEMAITRE VASCULAR INC's debt ratio is 7.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 30.1%.
Does LEMAITRE VASCULAR INC require dividend purification?
Yes, LEMAITRE VASCULAR INC has an impermissible income ratio of 4.99%, which means 4.99% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are LEMAITRE VASCULAR INC's key financial metrics?
LEMAITRE VASCULAR INC has a market capitalization of $2.4B, trailing P/E ratio of 42.3, and revenue of $250M. The company maintains a gross margin of 70.4% and a net margin of 23.1%. Return on equity stands at 15.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.